Adaptive Biotechnologies Corporation Stock price
Equities
ADPT
US00650F1093
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.21 USD | +11.07% | -3.60% | -34.49% |
Feb. 15 | JPMorgan Adjusts Price Target on Adaptive Biotechnologies to $8 From $11, Maintains Overweight Rating | MT |
Feb. 15 | Adaptive Biotechnologies' Q4 Loss Widens; Revenue Declines; Shares Down | MT |
Financials (USD)
Sales 2024 * | 176M | Sales 2025 * | 221M | Capitalization | 466M |
---|---|---|---|---|---|
Net income 2024 * | -193M | Net income 2025 * | -154M | EV / Sales 2024 * | 2.1 x |
Net cash position 2024 * | 96.2M | Net cash position 2025 * | 242M | EV / Sales 2025 * | 1.01 x |
P/E ratio 2024 * |
-2.44
x | P/E ratio 2025 * |
-3.1
x | Employees | 709 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.94% |
Latest transcript on Adaptive Biotechnologies Corporation
1 day | +11.07% | ||
1 week | -5.03% | ||
Current month | -21.90% | ||
1 month | -24.82% | ||
3 months | -37.18% | ||
6 months | -43.09% | ||
Current year | -34.49% |
Managers | Title | Age | Since |
---|---|---|---|
Harlan Robins
FOU | Founder | 51 | 09-09-07 |
Chad Robins
CEO | Chief Executive Officer | 49 | 09-09-07 |
Julie Rubinstein
PSD | President | 52 | 11-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Hershberg
BRD | Director/Board Member | 61 | 13-01-31 |
Peter Neupert
BRD | Director/Board Member | 68 | 13-12-31 |
Michael Pellini
BRD | Director/Board Member | 58 | 18-02-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.68% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 3.21 | +11.07% | 2,000,065 |
24-03-27 | 2.89 | +0.35% | 3,386,198 |
24-03-26 | 2.88 | -7.69% | 1,918,938 |
24-03-25 | 3.12 | -3.70% | 1,157,058 |
24-03-22 | 3.24 | -2.70% | 1,607,063 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.49% | 419M | |
-6.65% | 12.14B | |
+82.29% | 3.94B | |
-14.23% | 2.32B | |
-23.73% | 2.19B | |
-19.45% | 1.63B | |
+32.37% | 1.14B | |
+7.42% | 852M | |
-11.75% | 545M | |
+42.88% | 249M |